Related Experiment Video
Updated: Jul 10, 2026

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
Published on: December 24, 2016
Thrombin regulates the function of human blood dendritic cells
Manabu Yanagita1, Ryohei Kobayashi, Yoichiro Kashiwagi
1Department of Periodontology, Division of Oral Biology and Disease Control, Osaka University Graduate School of Dentistry, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan.
Thrombin stimulates blood dendritic cells (DC) via protease-activated receptor-1 (PAR-1), enhancing their immune-regulating functions. Monocyte-derived DC, however, do not express PAR-1 and are unresponsive to thrombin.
Area of Science:
- Immunology
- Hematology
- Cell Biology
Background:
- Thrombin, a key coagulation enzyme, activates various immune cells via protease-activated receptors (PARs).
- The role of thrombin in regulating dendritic cell (DC) function, crucial for immune responses, remains largely unexplored.
Purpose of the Study:
- To investigate the effects of thrombin on blood dendritic cells (DCs) and their functional responses.
Main Methods:
- Isolation of plasmacytoid DC (PDC) and myeloid DC (MDC) from peripheral blood mononuclear cells (PBMC).
- Stimulation of DCs with thrombin and assessment of cytokine release (MCP-1, IL-10, IL-12) and receptor expression (PAR-1).
- Evaluation of thrombin's effect on monocyte-derived DC (MoDC) and the impact of anti-PAR-1 antibodies and hirudin.
Main Results:
- Blood DCs (PDC and MDC) expressed PAR-1 and released MCP-1, IL-10, and IL-12 upon thrombin stimulation.
- In vitro-differentiated MoDCs lacked PAR-1 expression and were unresponsive to thrombin.
- Thrombin stimulation increased HLA-DR and CD86 expression on blood DCs, enhancing their ability to induce allogeneic T cell proliferation.
Conclusions:
- Thrombin modulates the function of blood DCs through PAR-1 signaling.
- These findings highlight a novel role for thrombin in regulating innate and adaptive immune responses via dendritic cells.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

